{"id":"speeda-and-trcs-speeda","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"SPEEDA and TRCS SPEEDA appear to be products from the Queen Saovabha Memorial Institute, a leading Thai institution known for snake venom research and antivenom production. The exact mechanism is not clearly documented in standard pharmaceutical databases, but products from this institute typically involve neutralizing antibodies or immunoglobulins against specific venom components.","oneSentence":"SPEEDA is a snake venom-derived antivenom or immunobiological therapeutic developed to treat envenomation or related conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:08:52.877Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Snake envenomation (specific species unknown)"}]},"trialDetails":[{"nctId":"NCT01137045","phase":"PHASE4","title":"Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG","status":"COMPLETED","sponsor":"Queen Saovabha Memorial Institute","startDate":"2010-06","conditions":"Rabies","enrollment":210}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["SPEEDA","TRCS SPEEDA"],"phase":"marketed","status":"active","brandName":"SPEEDA and TRCS SPEEDA","genericName":"SPEEDA and TRCS SPEEDA","companyName":"Queen Saovabha Memorial Institute","companyId":"queen-saovabha-memorial-institute","modality":"Biologic","firstApprovalDate":"","aiSummary":"SPEEDA and TRCS SPEEDA are interventions being studied in a clinical trial for the treatment of rabies. The study, NCT01137045, is being conducted by the Queen Saovabha Memorial Institute to assess the immunogenicity and safety of these interventions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}